GPhA Files Amicus Brief in Appeal of "Baseless Paragraph IV Certification" Case; Warns of...
orangebookblog.com     12-May-2008          

Takeda v. Mylan and Alphapharm, Nos. 2007-1269, -1270 (Fed. Cir.) In February 2006, the U.S. District Court for the Southern District of New York determined that Takeda's patent on pioglitazone, the active ingredient in ACTOS, is neither invalid for obviousness... [read full story]                    


View all news articles about*:
Corporate Courts Industrial Intellectual Issues Judiciary Lawsuits Legal Patents Property
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

/C O R R E C T I O N -- Simcere Pharmaceutical Group/

pharmiweb.co.uk     3 hrs ago   7 related          

Stocks mentioned in this article In the news release, ''Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study'', issued on Sept. 3 by Simcere Pharmaceutical Group SCR over PR Newswire,...                    

comments

                   

Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies(R)

pharmiweb.co.uk     7 hrs ago   5 related          

Merck Serono and Ablynx to Equally Contribute to Discover and Develop Nanobodies(R) Against two Targets in Oncology and Immunology and Equally Share the Resulting Profits GENEVA, SWITZERLAND | September 4, 2008 | Merck...                    

comments

Stockman fraud trial puts Enron in the shade

thefirstpost.co.uk     47 mins ago          

Reaganomics and the credit crunch are in the dock at David A Stockman’s trial, says Neil Lyndon The date has been set for what will surely be one of America's trials of the decade. Last week, a New York judge ruled that...                    

comments